Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2071 to 2085 of 9019 results

  1. Cryoablation for Desmoid-type Fibromatosis

    Topic prioritisation

  2. MRI-guided laser interstitial thermal therapy for early prostate cancer

    Topic prioritisation

  3. Transcatheter Tricuspid Valve Replacement

    Topic prioritisation

  4. Infrared lasers for treating onychomycosis

    Topic prioritisation

  5. Spirecut's Sono-Instruments to treat carpal tunnel syndrome and trigger finger

    Topic prioritisation

  6. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction

    Topic prioritisation

  7. Laparoscopic lumbar sympathectomy for foot hyperhidrosis

    Topic prioritisation

  8. External stimulation of the auricular branch of the vagus nerve

    Topic prioritisation

  9. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for glycemic control

    Topic prioritisation

  10. Talazoparib with enzalutamide for untreated hormone-sensitive metastatic prostate cancer with a homologous recombination repair mutation [ID6460]

    Awaiting development Reference number: GID-TA11534 Expected publication date: TBC

  11. Pembrolizumab with chemoradiation, then with or without olaparib, for untreated unresectable locally advanced non-small-cell lung cancer [ID6399]

    Awaiting development Reference number: GID-TA11499 Expected publication date: TBC

  12. Apalutamide with radical prostatectomy for untreated high-risk, localised or locally advanced prostate cancer [ID6471]

    Awaiting development Reference number: GID-TA11490 Expected publication date: TBC

  13. Aprocitentan for treating resistant hypertension [ID6681]

    Awaiting development Reference number: GID-TA11459 Expected publication date: TBC

  14. Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age who had symptoms before 13 years [ID6484]

    Awaiting development Reference number: GID-TA11632 Expected publication date: TBC

  15. Teprotumumab for treating thyroid eye disease [ID6432]

    Deferred Reference number: GID-TA11531